Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Revenue (2022 - 2025)

Historic Revenue for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $13.3 million.

  • Gossamer Bio's Revenue rose 4023.21% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year decrease of 8096.31%. This contributed to the annual value of $90.7 million for FY2024, which is N/A changed from last year.
  • Per Gossamer Bio's latest filing, its Revenue stood at $13.3 million for Q3 2025, which was up 4023.21% from $11.5 million recorded in Q2 2025.
  • Gossamer Bio's Revenue's 5-year high stood at $95.8 million during Q2 2024, with a 5-year trough of -$14.6 million in Q4 2024.
  • For the 4-year period, Gossamer Bio's Revenue averaged around $9.8 million, with its median value being -$3.5 million (2022).
  • Over the last 5 years, Gossamer Bio's Revenue had its largest YoY gain of 4023.21% in 2025, and its largest YoY loss of 8801.26% in 2025.
  • Over the past 4 years, Gossamer Bio's Revenue (Quarter) stood at -$3.5 million in 2022, then fell by 1.24% to -$3.5 million in 2023, then crashed by 317.77% to -$14.6 million in 2024, then skyrocketed by 190.92% to $13.3 million in 2025.
  • Its Revenue was $13.3 million in Q3 2025, compared to $11.5 million in Q2 2025 and $9.9 million in Q1 2025.